Roche and Ventana - Top 10 deals of 2008

FierceBiotech's top 10 deals of 2008 featuring Roche's $3.4 billion acquisition of Ventana Medical SystemsWho: Roche
With: Ventana
What: $3.4B buyout

Summary: After months of saying that it wouldn't boost its initial bid for the company, Roche upped its offer for Ventana Medical systems to $3.4 billion. Ventana creates diagnostic technologies that automate the process for examining human tissue, determining effective treatments for cancer and other infectious diseases, as well as evaluating drug safety. Roche hopes the the buyout will help it compete in the personalized medicine space. The company will add about 250 employees to Ventana and expand its R&D facilities. Overall, Roche plans to invest $100 million in the diagnostics company this year.

Roche and Ventana - Top 10 deals of 2008

Suggested Articles

The drug failed a futility analysis in March, but Biogen resurrected it after factoring in data generated after the cutoff for the interim assessment.

The negative top-line data deal a big blow to the prospects of a drug analysts tipped to achieve blockbuster sales if it cleared phase 3.

Intrepida Bio launched with $9.5 million from Sofinnova and Canaan Partners to develop anti-BAG3 antibodies for the treatment of cancer.